- Home
- DRIO vs COEP Comparison
DRIO vs COEP Comparison
Compare DRIO & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRIO
- COEP
- Stock Information
- Founded
- DRIO 2011
- COEP 2017
- Country
- DRIO United States
- COEP United States
- Employees
- DRIO N/A
- COEP N/A
- Industry
- DRIO Medical/Dental Instruments
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DRIO Health Care
- COEP Health Care
- Exchange
- DRIO Nasdaq
- COEP Nasdaq
- Market Cap
- DRIO 30.5M
- COEP 27.4M
- IPO Year
- DRIO N/A
- COEP N/A
- Fundamental
- Price
- DRIO $0.71
- COEP $9.47
- Analyst Decision
- DRIO Strong Buy
- COEP
- Analyst Count
- DRIO 2
- COEP 0
- Target Price
- DRIO $2.50
- COEP N/A
- AVG Volume (30 Days)
- DRIO 125.4K
- COEP 37.4K
- Earning Date
- DRIO 08-07-2025
- COEP 08-15-2025
- Dividend Yield
- DRIO N/A
- COEP N/A
- EPS Growth
- DRIO N/A
- COEP N/A
- EPS
- DRIO N/A
- COEP N/A
- Revenue
- DRIO $28,034,000.00
- COEP $62,874.00
- Revenue This Year
- DRIO $13.66
- COEP N/A
- Revenue Next Year
- DRIO $24.50
- COEP N/A
- P/E Ratio
- DRIO N/A
- COEP N/A
- Revenue Growth
- DRIO 47.20
- COEP N/A
- 52 Week Low
- DRIO $0.50
- COEP $2.31
- 52 Week High
- DRIO $1.55
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- DRIO 52.31
- COEP 62.24
- Support Level
- DRIO $0.69
- COEP $7.25
- Resistance Level
- DRIO $0.74
- COEP $9.90
- Average True Range (ATR)
- DRIO 0.04
- COEP 0.63
- MACD
- DRIO 0.00
- COEP 0.26
- Stochastic Oscillator
- DRIO 57.32
- COEP 85.62
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.